- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Active JNJ Drug
Total 259321 results
-
M.D. Anderson Cancer CenterActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma | Castration-Resistant...United States
-
Janssen Research & Development, LLCCompleted
-
Janssen-Cilag International NVCompleted
-
Janssen Research & Development, LLCCompletedRespiratory Syncytial Virus InfectionsUnited States, Taiwan, Japan, Korea, Republic of, France, Mexico, Brazil, Sweden, Argentina, Ukraine, Canada, Spain, Germany, Poland, Belgium, Russian Federation, South Africa, Australia, Bulgaria
-
Janssen Research & Development, LLCRecruitingProstatic NeoplasmsUnited States, France, Spain, Netherlands
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, France, Sweden
-
Janssen Research & Development, LLCCompletedFocal Onset SeizuresGermany, Korea, Republic of, Belgium, United States, Russian Federation, Poland, Ukraine, Spain
-
Janssen Research & Development, LLCTerminatedRespiratory Syncytial Virus InfectionsUnited States, Taiwan, Belgium, Hungary, Thailand, United Kingdom, Germany, Korea, Republic of, Bulgaria, Turkey, France, Italy, Poland, Spain, Brazil, Russian Federation, Japan, Argentina, Malaysia, Mexico, Sweden, South Africa
-
Janssen Research & Development, LLCNo longer available
-
Janssen BioPharma, Inc.Completed
-
CCTU- Cancer ThemeJanssen-Cilag Ltd.Completed
-
OncoVerity, Inc.Janssen Research & Development, LLC; argenxCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteSwitzerland, France
-
Janssen Research & Development, LLCCompletedHealthyBelgium, Netherlands
-
Royal Marsden NHS Foundation TrustJanssen, LPUnknownGastrooesophageal CancerUnited Kingdom
-
Furiex Pharmaceuticals, IncCompletedIrritable Bowel SyndromeUnited States, Canada, United Kingdom
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.RecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorJapan
-
Janssen Research & Development, LLCRecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorKorea, Republic of, United States, Germany, Spain, Netherlands
-
Rabin Medical CenterJanssen, LPRecruitingCentral Nervous System LymphomaIsrael
-
ActelionTerminatedPulmonary Arterial HypertensionGermany, Korea, Republic of, Israel, Singapore, United States, Russian Federation, Brazil, Netherlands, Malaysia, Saudi Arabia, United Kingdom, Hong Kong, France, United Arab Emirates, Argentina
-
Octimet Oncology N.V.Terminated
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen R&D IrelandTerminatedChronic Hepatitis C InfectionGermany
-
Janssen Research & Development, LLCCompletedMajor Depressive Disorder With Anxious DistressUnited States, Moldova, Republic of, Russian Federation, Ukraine, United Kingdom
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage IIB Prostate Cancer AJCC v8United States
-
Janssen Research & Development, LLCCompletedPhobic DisordersUnited States, Australia, Canada
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen-Cilag International NVCompleted
-
University of WashingtonNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCTerminatedProstate AdenocarcinomaUnited States
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCActive, not recruitingInvasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) PreventionUnited States, Poland, Belgium, Canada
-
Janssen Research & Development, LLCTerminatedRespiratory Syncytial VirusesAustralia, France, United Kingdom, Belgium, Taiwan, United States, Spain, Argentina, Mexico, Bulgaria, Malaysia, Japan, Sweden, Korea, Republic of, Canada, Netherlands, Brazil, Germany, Poland
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHealthy | Pharmacokinetics
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Pharmaceutical K.K.CompletedMultiple MyelomaJapan
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
Janssen Vaccines & Prevention B.V.CompletedHealthyUnited Kingdom, Germany, Spain, Netherlands
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen-Cilag, S.A.Completed
-
Janssen Research & Development, LLCActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, France, Canada, China, Israel, Belgium, United Kingdom, Italy, Argentina, Japan, Taiwan, Thailand, Korea, Republic of, Malaysia, Poland, Australia, Spain, Netherlands, Hungary, Turkey, Germany, India, Brazil, Russian Federation and more
-
National Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8United States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCCompleted